Drugs that affect uterine motility (Contractility) Flashcards
Uterine stimulants
promote/stimulate uterine contractility
Oxtyocics
oxytocin, pitocin, syntocinon
Therapeutic actions of Oxytocics
promote an increase in force, frequency and duration of uterine contractions
- initiates and or stimulates uterine contractions
- stimulates milk letdown reflex
Pharmacokinetics of Oxytocics
functions similarly to natural oxytocin (hormone produced in hypothalamus & stored in posterior pituitary)
- absorption- well absorbed from nasal mucosa
- distribution
- widely distributed in extracellular fluid
- small amounts reach fetal circulation
- metabolism/excretion- rapidly metabolized by kidney adn liver
- half life 3-9 minutes
Indications for use of Oxytocics
- Induction of labor- initiate uterine contractions prior to spontaneous onset of labor and/or contractions that will lead to labor and delivery
- Increase effectiveness of contractions- when inadequate or ineffective uterine contractions during labor
- Postpartum- control bleeding and promote involution
- Stimulation of milk letdown reflex- in breastfeeding mothers
Drug interactions of oxytocics
- severe hypertension may result if oxytocin given after administration of vasopressors
- Hypotension may result if used concurrently with cyclopropane anesthesia
Complications/ side-effects of oxytocin
- anti-diuretic effect- non electrolyte IV solutions should not be used for infusions may lead to water intoxication
- increased cardiac output which may lead to increased blood pressure
- IV bolus may lead to decreased blood pressure and tachycardia
- Increase chance of neonatal hyperbilirubinemia
- increased risk f abnormally strong or titanic contractions which leads to fetal distress (also placental perfusion decreases)
- Uterine overstimulation
- Increased risk of uterine rupture
- Increased chance of placental abruption
- associated with increased risk of epidurlal anesthesia and increased risk of c-section
Contraindications of Oxytocics
- Abnormal fetal lie, CPD, or cord presentation
- Prior surgery or trauma to the uterus
- Placental abnormalities- complete placenta previa or if a complete placental abruption has occurred or is suspected
- Non-reassuring FHR, fetal distress; and or positive stress test (OCT)
- Active gental herpes
- Abnormalities of uterus, cervix, pelvis, or vagina that are not compatible with a vaginal delivery
- Invasive cervical cancer
Implications of Oxytocics
*THE FDA RECOMMENDS THE USE OF PITCOIN ONLY WHEN MEDICALLY INDICATED. IT SHOULD NOT BE GIVEN FOR ELECTIVE INDUCTION OF LABOR
Indications for use when initiating labor
- Inadequate uterine contractions after PROM
- Post- term fetus or IUGR
- Fetus is jeopardy if no delivered ASAP
- Maternal medication problems ( severe Rh incompatibility, isoimmunizaton, diabetes or renal disease
- Preeclampsia/Eclampsia and or HELP
- intrauterine fetal demise (stillbirth)
- Logistics- history of precipitous labors (especially when must travel long distance for delivery)
Favorable indicatiors
conditions necessary for successful induction
- Bishops Pelvic Score- the higher the score the greater the chance of a favorable outcome
- 0 to 3 for each of area
- cervical dilation
- cervical effacement
- cervical consistency (firm, medium, or soft)
- station- related to ishial spines
- position (posterior vs anterior)
Nursing interventions/ responsibilities related to Oxytocics
- monitor contractions- frequency, duration, and strength
- Give IV piggyback with infusion pump
- Monitor FHR and maternal vital signs
- Stop infusion if unfavorable FHR
- Use electrolyte solution to lessen chance of antidiuretic effect
- monitor for water intoxication
Ergot Alkaloids
- sustained uterine contractions
- Methylergonovine (Methergine)
- Ergotrate ( Ergonovine)
Pharmacokentics of Ergot alkaloids
- effect uterine and smooth muscle stimulates adrenergic, dopaminergic, and serotonergic receptors which results in
- stimulation of uterine contractions
- constriction of arterioles and veins
Drug interatctions with Ergot alkaloids
- parenteral sympathomimetics and other ergot alkaloids administered together to result in increased vasomotor action and can lead to hypertension